Marico Boosts Stake in D2C Nutrition Brand Plix to 84.09% in ₹1,012 Cr All-Cash Deal

Mumbai — Fast-moving consumer goods (FMCG) major Marico Limited has aggressively tightened its grip on the high-growth wellness and nutrition sector. In its latest high-stakes transaction, the company has acquired an additional 24.09% stake in Satiya Nutraceuticals—the parent entity of the popular plant-based nutrition and personal care brand Plix—for ₹1,012.03 crore in an all-cash deal.

This multi-crore transaction elevates Marico’s cumulative shareholding in the direct-to-consumer (D2C) startup to a commanding 84.09%. The development underlines a broader, highly calculated strategy by legacy FMCG conglomerates to aggressively acquire, scale, and integrate disruptive digital-first brands to capture India’s rapidly evolving health-conscious consumer demographic.

Main Facts: Deal Breakdown and Future Tranches

The latest transaction is part of a larger, structured agreement that involves acquiring a cumulative 38.18% stake from Plix’s original founders and select early-stage institutional shareholders.

As part of this roadmap, Marico has lined up a subsequent tranche. The company is slated to acquire a final 14.09% stake in July 2027. The consideration for this upcoming tranche includes a baseline amount of up to ₹592 crore, supplemented by variable, performance-linked milestone payouts.

Through its ongoing investments in Satiya Nutraceuticals and its wholly-owned subsidiary Juzio, Marico has successfully broadened its addressable market. The conglomerate has expanded beyond its traditional legacy strongholds into value-added functional foods, next-generation nutrition, and premium personal care segments.

Founded in 2020 by Rishit Mehta and Akash Zaveri, Plix Life has carved a niche for itself as a Mumbai-based D2C powerhouse. The startup offers an extensive portfolio of science-backed, plant-based nutrition products. Its catalog ranges from specialized workout supplements and ingestible sunscreens to advanced hair growth serums and targeted skincare formulations.

Chronology of an Acquisition: From Initial Entry to Majority Control

Marico’s journey with Plix has unfolded in measured, strategic steps over the past few years, reflecting a phased "de-risking" approach typical of modern corporate venture integrations:

• July 2023: Marico made its maiden foray into the brand by acquiring a 37.75% stake in Plix for ₹369.01 crore. This initial investment allowed the FMCG major to test operational synergies and understand the pulse of the D2C wellness landscape. Back then, Plix’s cap table boasted prominent institutional backers such as Guild Capital and RPSG Ventures.
• May 2025: Bolstered by the brand’s performance, Marico steadily increased its foothold, picking up an additional 25.25% of the paid-up share capital.
• Present Day: With the latest ₹1,012.03 crore all-cash cash infusion for a 24.09% stake, Marico has cemented its status as the majority owner with an 84.09% holding.
• July 2027 (Upcoming): The final tranche will see Marico acquire the remaining 14.09% stake, sealing full ownership of the D2C enterprise.

Supporting Data: Explosive Financial Growth and Marico’s 2026 Buying Spree

The valuation metrics justifying Marico’s aggressive capital deployment are rooted in Plix’s phenomenal financial trajectory. According to regulatory disclosures, Plix parent Satiya Nutraceuticals registered a near-doubling of its consolidated revenue, surging to ₹864.31 crore in FY26 from ₹432.84 crore in FY25. This hyper-growth trajectory has positioned Plix as one of the standout success stories in India’s crowded D2C ecosystem.

Marico’s 2026 Acquisition Spree

Plix is not an isolated bet. Marico kicked off calendar year 2026 on an aggressive acquisition spree, diversifying its product portfolio across categories and geographies:

1. 4700BC: Marico snapped up a 93.27% stake in gourmet popcorn brand 4700BC’s parent entity, Zea Maize, from PVR INOX for ₹226.8 crore.
2. Cosmix Wellness: In February, the company picked up a 60% stake in Bengaluru-based plant-based protein startup Cosmix Wellness for ₹226 crore.
3. Skinetiq Joint Stock Company: Expanding its international footprint, Marico acquired a 75% stake in Vietnam-based Skinetiq for an estimated ₹262–350 crore.

These moves illustrate a clear corporate pivot: legacy giants are no longer relying solely on organic R&D. Instead, they are deploying capital reserves to buy market share and digital-native consumer loyalty.

Official Responses and Strategic Vision

Leadership from both sides has emphasized the long-term value creation potential of this consolidated partnership.

Marico’s management noted that the integration of Plix aligns seamlessly with the company’s vision of building high-margin, future-ready businesses outside its legacy core. By leveraging Marico’s sprawling offline distribution network, supply chain efficiencies, and marketing muscle, Plix is well-positioned to scale from a digital-first brand into a household omnichannel name.

Plix’s founders have similarly highlighted that partnering with an established FMCG titan provides the necessary operational leverage to expand manufacturing capacities, accelerate research and development (R&D) for novel plant-based formulations, and penetrate tier-2 and tier-3 Indian urban markets where wellness adoption is accelerating exponentially.

Implications: The Macro Shift in Indian FMCG

Marico’s consolidation of Plix is emblematic of a wider, structural transformation sweeping across the Indian FMCG landscape. Legacy giants—confronted by slowing growth in commoditized core portfolios and the rise of agile, digitally native brands—are aggressively acquiring direct-to-consumer innovators in the health, nutrition, personal care, and wellness segments.

Industry-Wide Consolidation Wave

The Plix deal mirrors several high-profile transactions across the sector:

• ITC and Yoga Bar: FMCG major ITC completed the acquisition of 100% of Yoga Bar’s parent, Sproutlife Foods, buying out the remaining 52.5% stake for approximately ₹645 crore.
• Emami and IncNut Digital: In a bid to capture the beauty and personal care market, Emami acquired a 60% stake in IncNut Digital—the parent company of D2C brands Vedix and SkinKraft—for up to ₹321 crore in an all-cash transaction.
• Hindustan Unilever (HUL) and OZiva: Cementing its wellness play, HUL acquired the remaining 49% stake in OZiva parent Zywie Ventures for ₹824 crore, taking full control of the plant-based nutrition brand.

What This Means for the Market

1. The Death of Standalone Scaling? As customer acquisition costs (CAC) rise on digital ad platforms like Meta and Google, independent D2C brands are finding it increasingly difficult to scale profitably without the balance sheet backing and distribution reach of legacy conglomerates.
2. Mainstreaming Wellness: Plant-based nutrition, ingestible beauty, and preventive health are no longer urban niche categories. Backed by FMCG distribution, these products are fast penetrating traditional retail shelves across India.
3. Valuation Discipline: While mega-deals continue to happen, acquirers are increasingly structuring transactions with performance-linked milestones (as seen in Marico’s 2027 tranche for Plix), ensuring founders remain incentivized to drive sustainable, bottom-line growth rather than vanity top-line metrics.

As Marico steers Plix toward its next phase of growth, the success of this integration will serve as a bellwether for how traditional Indian conglomerates can successfully digest and scale digital-first insurgent brands in a hyper-competitive market.